PLK1 and cervical cancer: Using the small molecule Plk1 inhibitor TAK-960, Inoue et al. also demonstrated a significantly radiosensitizing effect in a NSCLC xenograft model (H1299) cells and in a cervical cancer xenograft model (HeLa cells) [37].